Barclays »

Gt Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $705 1.4k 0.49

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Gt Biopharma

Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
Hrt Financial
Everhart Financial Group
SRS Capital Advisors
Opal Wealth Advisors
Northern Trust
49 Wealth Management
Alongside
Cetera Investment Advisers
SeaCrest Wealth Management
Kitching Partners
Pnc Financial Services
Advisor Group Holdings

View all funds holding Gt Biopharma